Search Results

We also touched on how COVID-19 affected her Ph.D. work.

limitations in structural integrity and immunogenicity. mRNA technology, demonstrated in the success of COVID -19 vaccines, is emerging as a promising method for antibody discovery.

From struggling to grip mice in early animal studies to thesis delays during COVID-19, Serafini's journey

Pandemic Journey and Global Challenges Yamina and Arthur discussed Arthur's experiences during the Covid -19 pandemic, his journey as a research fellow in Australia, and his transition to the role of Dean. personal health struggles, the growth of his university, and the faculty's successful response to the Covid

Pandemic Journey and Global Challenges Yamina and Arthur discussed Arthur's experiences during the Covid -19 pandemic, his journey as a research fellow in Australia, and his transition to the role of Dean. personal health struggles, the growth of his university, and the faculty's successful response to the Covid

Both agreed on the importance of adaptability, as unexpected situations like the Covid-19 pandemic can

GPCR research, developing biosensors for G protein activity, networking, mentorship, PhD resilience, COVID -19 challenges, and his aspiration to transition into biotechnology investment opportunities. Next Call for GPCR Papers Special Issue on Adhesion GPCRs GPCR Events, Meetings, and Webinars March 19

Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling

Silvio Gutkind sheds light on his work and life since the beginning of COVID restrictions. Silvio Gutkind highlights how his past experience proves useful in current COVID times and potential

Paul thinks broadly about science and has been actively publishing papers about his ideas on how COVID

Strategic Partners Dr. GPCR Podcast << Back to podcast list Dr. Fiona Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how the beta-adrenergic receptor in the heart is activated by adrenaline, during her undergraduate studies at Bath University. She then pursued her Ph.D. in neuroscience at Cambridge University. An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements of the GABAB receptor. One of her career path-defining moments came when she visited Dr. Chris Tate and Dr. Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK. As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery and development biotechnology company, Fiona and her team made considerable breakthroughs in the field of GPCR stabilization and structure-based drug design. Today, Dr. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD. Join me and learn more about her fascinating career trajectory. Dr. Fiona Marshall on the web LinkedIn Twitter Google Scholar MSD UK Dr. GPCR Ecosystem Enjoying the Dr. GPCR Podcast? Leave a Review. Leave a quick review to help more scientists find the show—and help us keep improving every episode. It takes <60 seconds and makes a big difference. ★ Review on Apple Podcasts ★ Rate on Spotify ✉️ Send feedback to the team Recent Podcast Articles The Truth About GPCR Product Launches: Years in the Making Innovative Data-Driven Solutions: The pHSense Revolution How a Failed Med School Dream Sparked a GPCR Biotech Revolution Thanks for listening to this podcast episode Follow us on your favorite Podcast Player << Previous Podcast Episode Next Podcast Episode >>

Strategic Partners Latest Podcast Episodes 2025-10-22 2025-08-19 2025-07-08 2025-09-22 2025-08-05 2025 06-11 2025-09-02 2025-07-22 2025-05-27 1 2 3 4 5 1 ... 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

envisions using these tools to detect GPCR autoantibodies , which are implicated in conditions like long COVID

#gpcr #drgpcr Published on February 19, 2025 Category Dr.

Structural and Molecular Insights into GPCR Activation July 21, 2023 GPCR Activation and Signaling May 19

Lefkowitz 2012 Chemistry Nobel Laureate ( Episode #27 ) 2nd Annual Summit Sep 13–19, 2021: The 2nd Dr Brian Kobilka 2012 Chemistry Nobel Laureate First Symposium May 19, 2023: Inaugural Dr.

| Sept 9, 2025 🔥 Watch course | Sept 2, 2025 🔥 Watch course | Aug 26, 2025 🔥 Watch course | Aug 19

Sep 19 - 25, 2025 Read Full Issue Design Assays That Tell the Truth Oct 3 - 9, 2025 Read Full Issue How

Select Category Select Event Select Format 1 2 3 4 5 1 ... 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

shorter transcripts starting from alternative exons at the intron 17/exon 18 boundary with new or exon 19 The cleaved BAI1 isoform has a 19 amino acid extracellular stalk that can serve as a receptor agonist

Don’t hesitate to reach out to us if you’d like to recommend a colleague as a guest. 19 Do you have any

It's easy. 1 2 3 4 5 1 ... 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Call for GPCR Papers NEW Special Issue on Adhesion GPCRs GPCR Events, Meetings, and Webinars March 19

Each party shall bear one-half of the arbitration fees and costs. 19.

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994). Caron at Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled Research Chairs since 2001 and was previously a Heart and Stroke Foundation of Canada MacDonald Scholar (1998

stability-activity tradeoffs, crystallography; started my independent lab at Northwestern University Medical School (1996

Caron and his family moved to Durham, NC in 1977, following receipt of his BSc in Chemistry from Laval Jeffrey Benovic (1985) Dr. Michel Bouvier (1985) Dr. Kathleen Caron - Co-host- (1970) Dr. Richard Cerione (1985) Dr. Brian Kolbilka (1987) Dr. Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr. Lee Limbird (1973) Dr. David Sibley (1988) Memories our panelists shared with us Enjoying the Dr. GPCR Podcast?

She received her BSc in Human Biology from King’s College London in 1997, and while her Ph.D. commenced

Before joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000 , he researched at the Institute of Pharmacology Russian Academy of Medical Sciences in Moscow (1988- 1996). He received a Ph.D. in pharmacology in 1992 from the Russian Academy of Medical Sciences and an M.D. in 1988 from the Second Moscow Medical Institute, Moscow, Russia.

was senior director and head of endocrinology and metabolism at Neurocrine Biosciences, Inc., from 1998 Prior to Neurocrine, from 1995 to 1998, he co-founded ScienceMedia Inc. to develop eLearning solutions Between 1992 to 1995 he led contract research efforts at Biosym Technologies to develop and apply computational